Rodney Dawson - Concepedia

Author

Rodney Dawson

Also Known As

Andreas Diacon, Andreas H. Diacon, Dawson R, Dawson, Rodney, E. Burhan, R Dawson, R J Dawson, R. Dawson, Rina Chaudhary, Rodney Dawson

138

Publications

Citations

H-Index

Concepts

All Affiliations

University of Cape Town Stellenbosch University Task Applied Science South African Tuberculosis Vaccine Initiative Radboud University Nijmegen

About

Rodney Dawson is an author at University of Cape Town specializing in medicine, tuberculosis, and tuberculosis diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.7K
2	Health Sciences	4	4	389
3	Engineering	3	3	192
4	Public Health	1	1	73
5	Allergy	1	1	11

Rodney Dawson

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial Andreas H. Diacon, Rodney Dawson, Florian von Groote-Bidlingmaier, The Lancet AntibioticsMedicineRandomised Trial14-Day Bactericidal ActivityAntibacterial Agent	2012	428
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial Martin J. Boeree, Norbert Heinrich, Rob E. Aarnoutse, The Lancet Infectious Diseases	2016	379
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis Martin J. Boeree, Andreas H. Diacon, Rodney Dawson, American Journal of Respiratory and Critical Care Medicine	2015	310
Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting Grant Theron, Jonny Peter, Richard N. van Zyl-Smit, American Journal of Respiratory and Critical Care Medicine	2011	308
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt, The Lancet Pulmonary TuberculosisPhase 2BTuberculosis PreventionPharmacologyTuberculosis	2015	248
Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study Josephine M. Bryant, Simon R. Harris, Julian Parkhill, The Lancet Respiratory Medicine	2013	214
Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients Andreas H. Diacon, Rodney Dawson, M. Hanekom, The International Journal of Tuberculosis and Lung Disease	2011	203
Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline Andreas H. Diacon, Rodney Dawson, Florian von Groote-Bidlingmaier, American Journal of Respiratory and Critical Care Medicine	2015	200
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment Sven O. Friedrich, Andrea Rachow, Elmar Saathoff, The Lancet Respiratory Medicine	2013	187
Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients Andreas H. Diacon, Rodney Dawson, M. Hanekom, Antimicrobial Agents and Chemotherapy Tuberculosis PreventionBactericidal ActivityPharmacotherapyAntimicrobial ChemotherapyDrug Resistance	2010	175

Page 1